Wenhai Sui
State Key Laboratory For Innovation And Transformation Of Luobing Theory, Key Laboratory Of Cardiovascular Remodeling And Function Research
Jinan, China
Jinan, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 41 publications
Erratum: RNF128 aggravates metabolic dysfunction-associated steatotic liver disease progression via stabilization of SCD1.
Journal: Hepatology (Baltimore, Md.)
Published: July 24, 2026
RNF128 aggravates metabolic dysfunction-associated steatotic liver disease progression via stabilization of SCD1.
Journal: Hepatology (Baltimore, Md.)
Published: December 12, 2025
Podocyte NPRC Deficiency Attenuates Glomerular Fibrosis in Diabetic Mice.
Journal: Circulation research
Published: June 25, 2025
Association between circulating selenium levels and arterial stiffness: a nationwide cross-sectional study.
Journal: International journal of surgery (London, England)
Published: May 13, 2025
ADAM17 knockdown is more effective than AT1R blocker in alleviating diabetic cardiomyopathy through downregulating the RhoA-ROCK1 pathway.
Journal: International immunopharmacology
Published: March 02, 2025
Uncoupling protein 1-mediated protective effects of β3-adrenergic receptor agonist on kidney fibrosis via promoting adipose tissue browning in diabetic mice.
Journal: International journal of biological macromolecules
Published: February 16, 2025
STING aggravates ferroptosis-dependent myocardial ischemia-reperfusion injury by targeting GPX4 for autophagic degradation.
Journal: Signal transduction and targeted therapy
Published: September 10, 2024
E3 ubiquitin ligase Listerin regulates macrophage cholesterol efflux and atherosclerosis by targeting ABCA1.
Journal: The Journal of clinical investigation
Published: August 28, 2024
Sweetener aspartame aggravates atherosclerosis through insulin-triggered inflammation.
Journal: Cell metabolism
Published: May 30, 2024
Cardiomyocyte-specific knockout of ADAM17 alleviates doxorubicin-induced cardiomyopathy via inhibiting TNFα-TRAF3-TAK1-MAPK axis.
Journal: Signal transduction and targeted therapy
Published: January 20, 2024
Last Updated: 09/26/2026